Delivery Order SPE2DB24D2205-SPE2DB25FEJAQ
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $50,513.86 on September 19, 2025, for the supply of Concerta ER 54 mg tablets (100 count). The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) with a ceiling value of $9,672.59. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency (DLA) awarded a $5,978.22 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $10,648.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with a completion date of August 6, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,475.54 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER 18 mg tablets (100-count package). This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a $9,956.84 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Concerta ER 54 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility and an ultimate completion date of July 11, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER 54 mg tablets (100 count) valued at $2,656.57. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract's ultimate completion date is set for September 12, 2025, and performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $47,631.00 for 100 tablets of Concerta ER 54 mg on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price, competitively awarded contract (with no set-aside designation) represents a pharmaceutical supply delivery under the company's existing DLA contract vehicle. The medication will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $1,010.88 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on August 28, 2025, with completion due by August 29, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,899.43 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100 count) on August 11, 2025, with ultimate completion by August 12, 2025. This firm fixed price delivery order carries no set-aside designation and was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJAQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Concerta ER 54 mg tablets (100-count) valued at $9,448.20. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through open competition, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/25/25 |